Scarica l'app Stockscreener
0.132
2.72%
0.0035
Dopo l'orario di chiusura:
.13
-0.002
-1.52%
Precedente Chiudi:
$0.1285
Aprire:
$0.1337
Volume 24 ore:
809.77K
Relative Volume:
0.49
Capitalizzazione di mercato:
$8.00M
Reddito:
$7,500
Utile/perdita netta:
$-10.96M
Rapporto P/E:
-0.0575
EPS:
-2.2943
Flusso di cassa netto:
$-11.41M
1 W Prestazione:
-21.33%
1M Prestazione:
-27.07%
6M Prestazione:
-43.71%
1 anno Prestazione:
-82.09%
Intervallo 1D:
$0.1297
$0.1383
Intervallo di 1 settimana:
$0.1231
$0.175
Portata 52W:
$0.10
$1.09
Azitra Inc Stock (AZTR) Company Profile
Nome
Azitra Inc
Settore
Industria
Telefono
203 646 6446
Indirizzo
21 Business Park Drive, Branford
Compare AZTR vs VRTX, MRNA, REGN, ARGX, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AZTR
Azitra Inc
|
0.132 | 10.17M | 7,500 | -10.96M | -11.41M | -2.2943 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Azitra Inc Borsa (AZTR) Ultime notizie
Azitra Advances ATR04-484 Trial to Second Cohort - TipRanks
Azitra advances ATR04-484 trial for cancer trea... - Pluang
Azitra advances skin rash treatment trial to second cohort By Investing.com - Investing.com Canada
Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance - PR Newswire
AZTR Forecast — Price Target — Prediction for 2027 - TradingView
Why Is AZTR Stock Rising Today? - Stocktwits
Azitra Launches At-the-Market Equity Offering Program - The Globe and Mail
Azitra Launches $3.5 Million At-The-Market Stock Offering - Minichart
Form 424B5 Azitra Inc For: 28 September By Investing.com - Investing.com Nigeria
Azitra Launches $3.5 Million ATM Equity Program With A.G.P./Alliance Global Partners - TradingView
A 3% fee on gross proceeds applies if Azitra (AZTR) sells stock under its new agreement. - Stock Titan
AZTR: Updated Valuation Reflects Cosmetic and EGFRi Rash Programs - Yahoo Finance
Enterprise value to EBITDA forward of Azitra Inc – AMEX:AZTR - TradingView
Azitra at H.C. Wainwright conference: pipeline leans on skin bacteria - Investing.com
Azitra at H.C. Wainwright conference: pipeline leans on skin bacteria By Investing.com - Investing.com Canada
Azitra Inc (AZTR) Ticks Higher: Micro-Cap Biotech Holds Above $0.17 SupportCovered Call Trade - siam.in
Azitra to Present Corporate Update at Investment Conference - TipRanks
Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire
Initial data on a program targeting fine lines and wrinkles will be shared by Azitra - Stock Titan
Azitra Inc (AZTR) Peer Comparison – Compare with Others - Value Research
AZTR News | AZITRA INC (NYSEARCA:AZTR) - ChartMill
Azitra Inc (AZTR) Holds at $0.17 as Tight Range Between $0.16 Support and $0.18 Resistance PersistsFibonacci Extension - dars.gov.et
Azitra Inc (AZTR) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Azitra (AZTR) Trading: Closes 13.25% Higher at $0.15; Immediate View: the Near-Term Reference Band Stretches From $0.14 to $0.16 under the Current SnapshotFibonacci Entry Signals - vinanet.vn
Azitra (AZTR) Levels: Finishes 4.81% Higher at $0.13 in the Current Update; Range Check - vinanet.vn
Azitra Regains NYSE American Listing Compliance Status - The Globe and Mail
Azitra (NYSE:AZTR) Strengthens Market Position After Listing Milestone - Kalkine Media
Branford bioscience firm regains NYSE compliance - Hartford Business Journal
Azitra regains compliance with NYSE American listing standards - Investing.com
Azitra regains compliance with NYSE American li... - Pluang
Azitra Regains NYSE American Compliance; .BC Indicator to Be Removed - TradingView
Azitra (NYSE: AZTR) wins back listing under new NYSE watch period - Stock Titan
Azitra regains compliance with NYSE American listing standards By Investing.com - Investing.com UK
Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards - PR Newswire
Azitra (AZTR) Earnings Comparison: The Bottom-Line Figure Trails Its Comparison in the Available Record; Post-Report Move: Shares Fall 7.61% in the Latest ReadingROA Comparison - vinanet.vn
Azitra (AZTR): Nantahala Capital reports 6.48M-share, 9.99% beneficial stake - Stock Titan
Nantahala Capital Partners (AZTR) discloses 8.40% beneficial stake in Azitra - Stock Titan
Azitra, Inc. (AZTR) stock price, news, quote and history - Yahoo Finance Australia
Azitra Reports Q2 Net Loss of $3.3 Million - Quiver Quantitative
Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates - PR Newswire
Azitra (NYSE American: AZTR) posts Q2 2026 loss but lifts equity above NYSE limits - Stock Titan
Azitra, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Azitra Inc (AZTR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AZTR Q1 2026 Earnings: EPS Misses Estimates Sharply; No Revenue ReportedWeak Earnings Momentum - dars.gov.et
Azitra Inc (AZTR) Stock News Today - TradingKey
AZTR|Azitra Inc|Price:0.133|Chg%:+0.002 - TradingKey
Azitra Inc Q1 2026 Earnings: Deep EPS Miss Raises Concern as Revenue Remains AbsentDividend Cut Risk - dars.gov.et
Azitra’s ATR12-351 Trial Completion Puts Rare-Disease Skin Drug on Investors’ Radar - TipRanks
AZTR Q1 2026 Earnings: Clinical-stage biotech posts wider-than-expected loss, shares declineGross Profit Margin - dars.gov.et
Azitra Inc (AZTR) Income Statement - TradingKey
Azitra Inc Revenue Breakdown – AMEX:AZTR - TradingView
Azitra Inc Azioni (AZTR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
0.82%
Capitalizzazione:
|
Volume (24 ore):